To date, all CVOTs for dipeptidyl peptidase 4 (DPP-4) inhibitors, 4-7 glucagon-like peptide-1 receptor agonists (GLP-1 RAs), 8-13 and sodium-glucose transport protein 2 (SGLT-2) inhibitors 14-16 have documented a lack of increased CV risk (non-inferiority) with the investigational product in patients with T2DM compared to placebo
Leptomeningeal metastasis from systemic cancer: review and update on management
Smart Supplement Strategies During Semaglutide Treatment Supplements tend to work best when theyre used with intention
Your appetite signals will recalibrate over 48 weeks as semaglutide stabilizes
In an additional, 30-week placebo-controlled, trial of patients with type 2 diabetes mellitus inadequately controlled with metformin comparing the maintenance of sitagliptin 100 mg versus withdrawal of sitagliptin when initiating basal insulin therapy, the event rate and incidence of documented symptomatic hypoglycemia (blood glucose measurement 70 mg/dL) did not differ between the sitagliptin and placebo groups
Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S
